| NCT ID | NCT03458520 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Soft Tissue |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2018-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2018-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Eligibility Criteria
Inclusion Criteria: * Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor. * We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs. * Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry. Exclusion Criteria: * Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl. * Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age). * Patient has a CNS primary tumor. * Pregnant women and fetuses
Contact & Investigator
Heike Daldrup-Link, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT03458520 clinical trial?
This trial is open to participants of all sexes, up to 40 Years, studying Soft Tissue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03458520 currently recruiting?
Yes, NCT03458520 is actively recruiting participants. Contact the research team at amuehe@stanford.edu for enrollment information.
Where is the NCT03458520 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT03458520 clinical trial?
NCT03458520 is sponsored by Stanford University. The principal investigator is Heike Daldrup-Link, MD at Stanford University. The trial plans to enroll 100 participants.